Boston Financial Mangement LLC Buys 818 Shares of Danaher Co. (NYSE:DHR)

Boston Financial Mangement LLC raised its stake in Danaher Co. (NYSE:DHR) by 0.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 165,168 shares of the conglomerate’s stock after buying an additional 818 shares during the quarter. Danaher comprises approximately 1.1% of Boston Financial Mangement LLC’s investment portfolio, making the stock its 23rd biggest holding. Boston Financial Mangement LLC’s holdings in Danaher were worth $37,914,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Kentucky Retirement Systems Insurance Trust Fund lifted its stake in Danaher by 11.6% in the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock valued at $4,874,000 after buying an additional 2,202 shares in the last quarter. Fort Pitt Capital Group LLC lifted its position in shares of Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after purchasing an additional 7,421 shares in the last quarter. ORG Partners LLC lifted its position in shares of Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after purchasing an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. lifted its position in shares of Danaher by 1.2% in the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after purchasing an additional 2,465 shares in the last quarter. Finally, Generate Investment Management Ltd bought a new stake in shares of Danaher in the fourth quarter worth $8,044,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Robert W. Baird cut their price objective on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a research report on Friday, December 13th. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective on the stock in a research report on Thursday, October 31st. Finally, Stifel Nicolaus boosted their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 10.90% of the stock is currently owned by company insiders.

Danaher Price Performance

NYSE:DHR opened at $205.23 on Thursday. Danaher Co. has a one year low of $196.80 and a one year high of $281.70. The company has a market cap of $148.24 billion, a P/E ratio of 38.87, a P/E/G ratio of 2.63 and a beta of 0.83. The firm’s fifty day moving average price is $227.74 and its two-hundred day moving average price is $247.80. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the company earned $2.09 EPS. Equities analysts expect that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.53%. Danaher’s payout ratio is presently 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.